Get started
Author

Rayan Dakroub

ORCID: 0009-0009-3621-6931
Observed ORCID: 0009-0009-3621-6931
OpenAlex ID: A5077370698
PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer
2022 · Samyuktha Suresh, Solène Huard, et al. · Cancers · 44
PDF
Therapeutic Advantage of Targeting PRMT5 in Combination with Chemotherapies or EGFR/HER2 Inhibitors in Triple-Negative Breast Cancers
2023 · Rayan Dakroub, Solène Huard, et al. · Breast Cancer Targets and Therapy · 14
PDF
Targeting the double-edged sword: cytokines in the pathogenesis and treatment of autoimmune diseases
2025 · Fatima Dandash, Zahraa Salhab, et al. · Inflammopharmacology · 10
Expression, Localization and Prognosis Association of MEP50 in Breast Cancer
2022 · Samyuktha Suresh, Mathilde Vinet, et al. · Cancers · 10
PDF
CARM1-mediated methylation controls interactions of ALIX with key partners important for cytokinesis
2025 · Solène Huard, Samyuktha Suresh, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
Receptor tyrosine kinases in major depressive disorder
2023 · Fatima Dakroub, Youmna El Orfali, et al. · Elsevier eBooks · 1
Investigating PRMT5 functions in triple-negative breast cancers
2023 · Rayan Dakroub · theses.fr (ABES)
Abstract 4031: PRMT1 regulates EGFR and Wnt signaling pathways and is a promising target for combinatorial treatment of breast cancer
2022 · Samyuktha Suresh, Solène Huard, et al. · Cancer Research
Ketogenic Diet: Implications for Treatment and Injury in Neuropsychiatry and Motor Functioning
2022 · Fatima Dakroub, Habib Alkalamouni, et al. · Nutritional neurosciences
Works count: 10
Citation count: 81
H-index: 4
I10-index: 4
Year
Topic
Type